News
ABX-CRO Registered in India as Radiopharmaceutical CRO
A major milestone for ABX-CRO! We are now an officially registered and accredited Radiopharmaceutical CRO with CDSCO in India, specialized in radiopharmaceutical clinical trials.
This marks an important step in expanding our global footprint and strengthening our commitment to advancing nuclear medicine research in one of the world's fastest-growing pharmaceutical markets.
The registration enables ABX-CRO to directly conduct and manage radiopharmaceutical clinical trials in India, leveraging the country's large patient populations, experienced clinical investigators, and growing nuclear medicine infrastructure.
ABX-CRO India operates from New Delhi under the leadership of Taranjit Singh, CEO.
